Literature DB >> 6633639

Enzyme replacement in grafted nerve of twitcher mouse.

F Scaravilli, K Suzuki.   

Abstract

"Twitcher' is a recently recognized mouse mutant which, on the basis of morphological and enzymatic criteria, represents a murine model for globoid-cell leukodystrophy in man. In the twitcher mouse, myelin sheaths develop normally in peripheral nerves until about the fifteenth day when the rate of myelination declines, demyelination begins and Krabbe-type inclusions are seen in macrophages and Schwann cells. With age, demyelination becomes extensive, affecting fibres of all sizes. The axons are relatively spared, although they are smaller than normal. Twitcher peripheral nerves transplanted into normal hosts show, after 2 months, all the characteristics associated with globoid-cell leukodystrophy. After longer periods of time, however, pathological changes within the grafts appear considerably improved with only occasional evidence of myelin loss, little endoneurial oedema and few globoid cells. Migration of host Schwann cells into the graft can be excluded as a possible explanation. In the experiments reported here, we have attempted to determine whether the morphological improvement of grafted twitcher nerves is accompanied by an increase in activity of the enzyme galactosylceramidase. Our results show that galactosylceramidase activity in twitcher sciatic nerves grafted into normal hosts is variable after 1-2 months but indistinguishable from those in the host nerves and much higher than those in intact twitcher nerves after 4.5-9 months. In addition to migration of host Schwann cells, other tissues originating from the host can be excluded as cause of the high enzyme activity. This is the first evidence of long-term in vivo enzyme replacement, accompanied by improved pathology, in a genetic sphingolipidosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6633639     DOI: 10.1038/305713a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  10 in total

Review 1.  Enzyme-replacement therapy: problems and prospects.

Authors:  B Rademaker; J Raber
Journal:  Pharm Weekbl Sci       Date:  1989-10-20

2.  Persistence of psychosine in brain lipid rafts is a limiting factor in the therapeutic recovery of a mouse model for Krabbe disease.

Authors:  A B White; F Galbiati; M I Givogri; A Lopez Rosas; X Qiu; R van Breemen; E R Bongarzone
Journal:  J Neurosci Res       Date:  2010-12-29       Impact factor: 4.164

3.  Galactocerebrosidase-deficient oligodendrocytes maintain stable central myelin by exogenous replacement of the missing enzyme in mice.

Authors:  Yoichi Kondo; David A Wenger; Vittorio Gallo; Ian D Duncan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-13       Impact factor: 11.205

Review 4.  The myelin mutants as models to study myelin repair in the leukodystrophies.

Authors:  Ian D Duncan; Yoichi Kondo; Su-Chun Zhang
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

Review 5.  Mouse forward genetics in the study of the peripheral nervous system and human peripheral neuropathy.

Authors:  Darlene S Douglas; Brian Popko
Journal:  Neurochem Res       Date:  2008-05-15       Impact factor: 3.996

6.  Disorders in myelination in the twitcher mutant: immunohistochemical and biochemical studies.

Authors:  K Mikoshiba; M Fujishiro; S Kohsaka; H Okano; K Takamatsu; Y Tsukada
Journal:  Neurochem Res       Date:  1985-08       Impact factor: 3.996

7.  High-throughput screening of stem cell therapy for globoid cell leukodystrophy using automated neurophenotyping of twitcher mice.

Authors:  Brittni A Scruggs; Annie C Bowles; Xiujuan Zhang; Julie A Semon; Evan J Kyzar; Leann Myers; Allan V Kalueff; Bruce A Bunnell
Journal:  Behav Brain Res       Date:  2012-08-20       Impact factor: 3.332

8.  Establishment of a galactocerebrosidase-deficient twitcher mouse cell line that expresses galactocerebrosidase activity in hybrids with control human fibroblasts.

Authors:  J T Konola; T A Lyerla; M C Skiba; S Raghavan
Journal:  In Vitro Cell Dev Biol       Date:  1988-06

9.  Waning efficacy in a long-term AAV-mediated gene therapy study in the murine model of Krabbe disease.

Authors:  Gregory J Heller; Michael S Marshall; Yazan Issa; Jeffrey N Marshall; Duc Nguyen; Emily Rue; Koralege C Pathmasiri; Miriam S Domowicz; Richard B van Breemen; Leon M Tai; Stephanie M Cologna; Stephen J Crocker; Maria I Givogri; Mark S Sands; Ernesto R Bongarzone
Journal:  Mol Ther       Date:  2021-01-26       Impact factor: 11.454

Review 10.  Pre-clinical Mouse Models of Neurodegenerative Lysosomal Storage Diseases.

Authors:  Jacob M Favret; Nadav I Weinstock; M Laura Feltri; Daesung Shin
Journal:  Front Mol Biosci       Date:  2020-04-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.